Goldman Sachs Group Inc Elevation Oncology, Inc. Transaction History
Goldman Sachs Group Inc
- $555 Billion
- Q1 2024
A detailed history of Goldman Sachs Group Inc transactions in Elevation Oncology, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 551,079 shares of ELEV stock, worth $2.22 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
551,079Holding current value
$2.22 Million% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding ELEV
# of Institutions
65Shares Held
44MCall Options Held
700Put Options Held
0-
Farallon Capital Management LLC San Francisco, CA3.89MShares$15.6 Million0.09% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.37MShares$13.5 Million0.04% of portfolio
-
Tang Capital Management LLC San Diego, CA3.06MShares$12.3 Million1.91% of portfolio
-
Balyasny Asset Management LLC Chicago, IL3.06MShares$12.3 Million0.03% of portfolio
-
Aisling Capital Management LP New York, NY2.83MShares$11.4 Million4.98% of portfolio
About Elevation Oncology, Inc.
- Ticker ELEV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,300,900
- Market Cap $93.7M
- Description
- Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...